The dataset connects claims, labs and EHR, including physician notes to analyse: Who meets drug label or payer criteria based on actual BMI and comorbidities How titration and dosing progress in real-world care What metabolic outcomes patients achieve over time Which safety signals, such as liver or renal changes, emerge across populations Why patients discontinue or switch treatments, as documented in notes See real-world GLP-1 evidence in action Register for our webinar where we dive deeper into GLP-1 real-world evidence
Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs
Think of a G one as your all-in-one nutritional insurance packed with vitamins and minerals, pre and probiotics, superfoods, all in one convenient scoop
Blockquote When prescribing SGLT2 inhibitors, one should also consider the potential adverse effects
If you're ready to experience the difference a direct wellness boost can make, we invite you to explore your options with us